Clinical Trial Update: Empiric Quinidine for Asymptomatic Brugada Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating empiric quinidine for asymptomatic Brugada syndrome was withdrawn after phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Brugada Syndrome

Drugs mentioned

• Quinidine (quinidine)

Snippet

Sponsor: International Registry of Asymptomatic Brugada Syndrome | Conditions: Arrhythmia | Phase 2, Phase 3 | Status: WITHDRAWN